LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 62.29 | 84.90 | 1109 | 7934 | 0.1398 | 0.4808 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 62.29 | 84.90 | 5406 | 7934 | 0.6813 | 0.8861 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 62.29 | 84.90 | 614 | 7934 | 0.0774 | 0.3529 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 62.29 | 84.90 | 6806 | 7934 | 0.8578 | 0.9537 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 63.99 | 84.90 | 1172 | 8212 | 0.1427 | 0.4888 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 63.99 | 84.90 | 5649 | 8212 | 0.6879 | 0.8897 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 63.99 | 84.90 | 607 | 8212 | 0.0739 | 0.3475 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 63.99 | 84.90 | 7092 | 8212 | 0.8636 | 0.9560 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 65.70 | 84.90 | 1255 | 8484 | 0.1479 | 0.5000 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 65.70 | 84.90 | 5834 | 8484 | 0.6876 | 0.8904 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 65.70 | 84.90 | 632 | 8484 | 0.0745 | 0.3528 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 65.70 | 84.90 | 7370 | 8484 | 0.8687 | 0.9581 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 67.41 | 84.90 | 1289 | 8766 | 0.1470 | 0.5017 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 67.41 | 84.90 | 6003 | 8766 | 0.6848 | 0.8899 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 67.41 | 84.90 | 595 | 8766 | 0.0679 | 0.3378 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 67.41 | 84.90 | 7567 | 8766 | 0.8632 | 0.9565 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 69.11 | 84.90 | 1349 | 8988 | 0.1501 | 0.5086 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 69.11 | 84.90 | 6238 | 8988 | 0.6940 | 0.8943 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 69.11 | 84.90 | 641 | 8988 | 0.0713 | 0.3506 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 69.11 | 84.90 | 7838 | 8988 | 0.8721 | 0.9597 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 70.81 | 84.90 | 1477 | 9132 | 0.1617 | 0.5269 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 70.81 | 84.90 | 6392 | 9132 | 0.7000 | 0.8970 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 70.81 | 84.90 | 645 | 9132 | 0.0706 | 0.3505 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 70.81 | 84.90 | 8093 | 9132 | 0.8862 | 0.9645 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 72.52 | 84.90 | 1573 | 9214 | 0.1707 | 0.5399 | MN20160318_Q02 | E16 |